The study and publication of this infographic were funded by Sanofi.
Influenza infection is associated with an increased risk of acute cardiovascular events, and older adults are particularly vulnerable. This infographic presents FLUNITY-HD, a pooled analysis of the DANFLU-2 and GALFLU studies assessing high-dose versus standard-dose influenza vaccines against cardio-respiratory hospitalizations in adults aged 65 years and older.
Learn:
- What did FLUNITY-HD reveal about cardio-respiratory hospitalizations with high-dose versus standard-dose influenza vaccination?
- How was heart failure hospitalization risk reduced with high-dose compared with standard-dose influenza vaccine?
- Were the benefits of high-dose versus standard-dose influenza vaccination consistent across patients at varying cardiovascular risk, including higher-risk groups?
To explore the full FLUNITY-HD infographic on a wider range of hospitalization outcomes – click here:
